Geron | GERN - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Amgen USD 4.78B 1.12B 2026-03
Bio Techne USD 235.92M 5.5M 2026-03
Cassava Sciences USD 13.55M 1.69M 2025-12
Cytokinetics USD 200.58M 4.46M 2026-03
Esperion Therapeutics USD 83.21M 14.06M 2025-12
Exelixis USD 359.47M 3.28M 2026-03
Genmab DKK 798M 235M 2025-12
Geron USD 52.07M 6.73M 2026-03
Gilead Sciences USD 23.52B 18.55B 2026-03
Incyte USD 5.62B 4.5B 2026-03
MacroGenics USD 21.2M 32.13M 2026-03
Novartis USD 9.29B 507M 2026-03
Novavax USD 126.2M 23.62M 2025-12